Literature DB >> 519931

Dose-dependent elimination kinetics of theophylline.

L J Lesko.   

Abstract

There are an increasing number of clinical and experimental studies appearing in the literature suggesting that the elimination kinetics of theophylline may be dose-dependent in man. Evidence of nonlinearity includes observations that steady-state serum theophylline concentrations may increase disproportionately with increases in dose and that the elimination half-life of theophylline after multiple doses is longer than after single doses. Theophylline is apparently eliminated by parallel Michaelis-Menten and first-order kinetics. Although no specific studies of theophylline metabolism have been carried out to determine the causes of nonlinearity, it would appear that 1-demethylation of theophylline is a potentially saturable metabolic pathway. Dietary methylxanthines or their metabolites may influence the rate of elimination of theophylline and contribute to the causes of nonlinearity. Until the elimination kinetics of theophylline have been studied in more detail as a function of dose, it would seem prudent to increase doses of theophylline cautiously to minimise the risks of adverse side effects which might be associated with unexpected accumulation of theophylline.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519931     DOI: 10.2165/00003088-197904060-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  19 in total

1.  Dose-dependent kinetics of theophylline disposition in asthmatic children.

Authors:  M Weinberger; E Ginchansky
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

2.  The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings].

Authors:  J Caldwell; R Lancaster; T J Monks; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

3.  Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.

Authors:  M W Weinberger; R A Matthay; E J Ginchansky; C A Chidsey; T L Petty
Journal:  JAMA       Date:  1976-05-10       Impact factor: 56.272

4.  Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

Authors:  M M Weinberger; E A Bronsky
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

Review 6.  Diphenylhydantoin metabolism. A prospective review.

Authors:  A J Glazko
Journal:  Drug Metab Dispos       Date:  1973 Sep-Oct       Impact factor: 3.922

7.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

8.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05

9.  Oral aminophylline therapy. Increased dosage requirements in children.

Authors:  D E Zaske; K W Miller; E L Strem; S Austrian; P B Johnson
Journal:  JAMA       Date:  1977-04-04       Impact factor: 56.272

10.  Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.

Authors:  D D Shen; M Fixley; D L Azarnoff
Journal:  J Pharm Sci       Date:  1978-07       Impact factor: 3.534

View more
  19 in total

1.  [Not Available].

Authors:  J Matte; M Lapointe; M Lebel
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

Review 2.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

3.  Effect of zileuton on theophylline pharmacokinetics.

Authors:  G R Granneman; R A Braeckman; C S Locke; J H Cavanaugh; L M Dubé; W M Awni
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

4.  Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.

Authors:  S Dadashzadeh; H Tajerzaden
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

5.  Slow release theophyllines and chronic bronchitis.

Authors:  G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

Review 6.  Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.

Authors:  J G Wagner
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

7.  The interaction of erythromycin with theophylline.

Authors:  O Paulsen; P Höglund; L G Nilsson; H I Bengtsson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  The influence of antacid on the absorption of two different sustained-release formulations of theophylline.

Authors:  K I Myhre; R A Walstad
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

9.  Pharmacokinetics of theophylline: a dose-range study.

Authors:  V Rovei; F Chanoine; M Strolin Benedetti
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

Review 10.  Role of extracorporeal drug removal in acute theophylline poisoning. A review.

Authors:  A Heath; K Knudsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.